Sean Saint

CIK: 0002048593

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBNX

Beta Bionics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

BBNX
Beta Bionics, Inc.
Sep 3, 2026
Sale(S)
Direct
5.6K shares at avg. $20.08$113K
BBNX
Beta Bionics, Inc.
Sep 2, 2026
Sale(S)
Direct
16.9K shares at avg. $19.11$322K
BBNX
Beta Bionics, Inc.
Jun 2, 2026
Sale(S)
Direct
16.9K shares at avg. $12.61$213K
BBNX
Beta Bionics, Inc.
Mar 2, 2026
Sale(S)
Direct
3.4K shares at avg. $12.36$42K
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
287.9K shares-
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Direct
343.3K shares-
BBNX
Beta Bionics, Inc.
Dec 2, 2025
Sale(S)
Direct
3.3K shares at avg. $29.34$96K
BBNX
Beta Bionics, Inc.
Sep 2, 2025
Sale(S)
Direct
3.4K shares at avg. $18.86$63K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
311 shares at avg. $18.69$6K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
2.2K shares at avg. $18.15$40K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
943 shares at avg. $17.03$16K
BBNX
Beta Bionics, Inc.
Feb 27, 2025
Award(A)
Direct
108K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
467.9K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
494.2K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
749.4K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
83.3K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
54.9K shares-
BBNX
Beta Bionics, Inc.
Jan 29, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
467.9K shares-

		Type	Shares	Price		Ownership
Sep 3, 2026	BBNX Beta Bionics, Inc.	Sale(S)	5,641	$20.08	$113,259	Direct
Sep 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	16,867	$19.11	$322,381	Direct
Jun 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	16,872	$12.61	$212,707	Direct
Mar 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	3,384	$12.36	$41,832	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	287,944	-	-	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A)	343,269	-	$0	Direct
Dec 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	3,278	$29.34	$96,163	Direct
Sep 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	3,359	$18.86	$63,361	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	311	$18.69	$5,813	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	2,185	$18.15	$39,655	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	943	$17.03	$16,057	Direct
Feb 27, 2025	BBNX Beta Bionics, Inc.	Award(A)	108,000	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	467,944	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	494,198	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	749,445	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	83,268	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	54,911	-	-	Direct
Jan 29, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	467,944	-	-	Direct

1-18 of 18 transactions

About Saint Sean

Saint Sean (SEC CIK 0002048593) files insider reports with the SEC as President & CEO of Beta Bionics, Inc. (BBNX).

Signal8 holds 12 ownership filings by Saint Sean (1 Form 3, 11 Form 4), filed between Jan 29, 2025 and Sep 4, 2026. Those filings report 18 transactions, from Jan 29, 2025 to Sep 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Saint Sean's filings is in IRVINE, CA.

Recent filings by Saint Sean

Sep 3, 2026: Open-market sale of BBNX shares (Form 4, code S).
Sep 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jun 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Mar 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Feb 27, 2026: Grants or awards of BBNX derivative securities (2 lines, Form 4, code A).

Other insiders filing for Beta Bionics, Inc. (BBNX)

Mensinger Mike, Chief Product Officer
Hopman Mark, Chief Commercial Officer
Jones Christy, Director
Russell Steven Jon, Chief Medical Officer
Feider Stephen, Chief Financial Officer
MICHEL GERARD J, Director

How to read Form 4 transaction codes